Litigation
Jun. 6, 2014
GlaxoSmithKline to settle claims involving drug promotion
California will receive more than $7 million of a $105 million settlement announced on Wednesday between pharmaceutical giant GlaxoSmithKline and more than 40 states to resolve allegations of illegal medication promotion.
Daily Journal Staff Writer
California will receive more than $7 million of a $105 million settlement announced Wednesday between pharmaceutical giant GlaxoSmithKline and more than 40 states to resolve allegations of illegal medication promotion.
The states alleged the British-based company unlawfully promoted asthma drug Advair, and antidepressant drugs Paxil and Wellbutrin for uses not approved by the FDA.
"Pa...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In